Webinars
9 Jan 2024
17:00-18:00 CET/CEST
Jurij Hanžel, UMC Ljubljana, Slovenia
Lisa Schots, Ghent University Hospital, Belgium
Immune-mediated inflammatory diseases (IMIDs) (Pt. 1)
13 Feb 2024
17:00-18:00 CET/CEST
James Bluett, University of Manchester, UK
Gilles Paintaud, Tours University, France
IMIDs (Pt. 2) & Therapeutic antibodies versus small molecules
12 Mar 2024
17:00-18:00 CET/CEST
Iris Minichmayr, Medical University of Vienna, Austria
Erwin Dreesen, KU Leuven, Belgium
Therapeutic drug monitoring (TDM)
9 Apr 2024
17:00-18:00 CET/CEST
Katarina Vučićević, University of Belgrade, Serbia
Marlene Santos, Polytechnic Institute of Porto, Lisbon
Dose stratification versus TDM
14 May 2024
17:00-18:00 CET/CEST
Pawel Kawalec, Jagiellonian University, Poland
Isabelle Huys, KU Leuven, Belgium
Pharmacoeconomics and patient preferences
11 Jun 2024
17:00-18:00 CET/CEST
Vincent Aranzana-Climent, University of Poitiers, France
Elisabet Nielsen, Uppsala University, Sweden
Pharmacometrics and model-informed precision dosing (MIPD)
10 Sep 2024
17:00-18:00 CET/CEST
Paulo Paixão, Lisbon University, Portugal
Gregor Schaffar, Sandoz, Holzkirchen, Germany
Regulatory and industry perspective on TDM/MIPD
8 Oct 2024
17:00-18:00 CET/CEST
Sebastian Wicha, University of Hamburg, Germany
Ron Keizer, InsightRx, San Francisco, California, USA
Software tools for MIPD
12 Nov 2024
17:00-18:00 CET/CEST
Silje Skrede, University of Bergen, Norway
Núria Padullés-Zamora, Bellvitge University Hospital, Barcelona, Spain
Experience with MIPD, and the role of analytics
10 Dec 2024
17:00-18:00 CET/CEST
Nikola Stefanovic, University of Nis, Serbia
Mehmet Itik, Dokuz Eylul University, Turkey
Serbulent Unsal, Antiverse, Karadeniz Technical University, Turkey
Artificial intelligence in TDM/MIPD